Noninvasive subcellular imaging in breast cancer risk assessment: Construction of diagnostic windows

Personalized Medicine

Volumn 8, Issue 3, 2011, Pages 321-330

  Yeghiazaryan, Kristina ^a   Cebioglu, Melanie ^a   Braun, Michael ^a   Kuhn, Walther ^a   Schild, Hans H ^a   Golubnitschaja, Olga ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

benign breast alteration; biomarker; blood tests; breast cancer; comet assay; personalized medicine; predictive diagnostics; risk assessment; specific patterns

Indexed keywords

TUMOR MARKER;

ARTICLE; BREAST CANCER; CANCER GROWTH; COMET ASSAY; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 79958162129     PISSN: 17410541     EISSN: 1744828X     Source Type: Journal    
DOI: 10.2217/pme.11.17     Document Type: Article

References (28)

1. Ross JS, Hortobagyi GN: Molecular Oncology of Breast Cancer. Jones & Bartlett Learning Publisher, MA, USA (2005).
2. Braun M, Pölcher M, Schrading S, et al.: Influence of preoperative MRI on the surgical management of patients with operable breast cancer. Breast Cancer Res. Treat. 111(1), 179-187 (2008). (Pubitemid 352009236)
3. Ross JS: Integrated diagnostics and personalized therapeutics in oncology. In: Predictive Diagnostics and Personalized Treatment: Dream or Reality. Golubnitschaja O (Ed.). Nova Science Publishers, Inc., NY, USA, 399-431 (2009).
4. Braun M, Fountoulakis M, Yeghiazaryan K, Schild HH, Kuhn W, Golubnitschaja O: How realistic are non-invasive approaches in breast cancer prediction? In: Predictive Diagnostics and Personalized Treatment: Dream or Reality. Golubnitschaja O (Ed.). Nova Science Publishers, Inc., NY, USA, 433-446 (2009).
5. Yeghiazaryan K, Braun M, Mamlouk S, Schild HH, Golubnitschaja O: Are side-effects of irradiation predictable for treatment of breast cancer patients? In: Predictive Diagnostics and Personalized Treatment: Dream or Reality. Golubnitschaja O (Ed.). Nova Science Publishers, Inc., NY, USA, 447-456 (2009).
6. Gahan PB: Circulating nucleic acids in plasma and serum: diagnosis and prognosis in cancer. EPMA J. 1(3), 503-512 (2010).
7. Mallmann MR, Staratschek-Jox A, Rudlowski C, et al.: Prediction and prognosis: impact of gene expression profiling in personalized treatment of breast cancer patients. EPMA J. 1(3), 421-438 (2010).
8. Debald M, Wolfgarten M, Walgenbach-Brnagel G, Kuhn W, Braun M: Non-invasive proteomics - thinking about personalized breast cancer screening and treatment. EPMA J. 1(3), 413-420 (2010).
9. Yeghiazaryan K, Mamlouk S, Trog D, et al.: Irradiated breast cancer patients demonstrate subgroup-specific regularities in protein expression patterns of circulating leukocytes. Cancer Genomics Proteomics 4(6), 411-418 (2007).
10. Golubnitschaja O: Cell cycle checkpoints: the role and evaluation for early diagnosis of senescence, cardiovascular, cancer, and neurodegenerative diseases. Amino Acids 32(3), 359-371 (2007). (Pubitemid 46559587)
11. Cebioglu M, Schild HH, Golubnitschaja O: Diabetes mellitus as a risk factor for cancer: stress or viral etiology? Infect. Disord. Drug Targets 8(2), 76-87 (2008). (Pubitemid 351936177)
12. Braun M, Fountoulakis M, Papadopoulou A, et al.: Down-regulation of microfilamental network-associated proteins in leukocytes of breast cancer patients: potential application to predictive diagnosis. Cancer Genomics Proteomics 6(1), 31-40 (2009).
13. Golubnitschaja O, Costigliola V: Common origin but individual outcomes: time for new guidelines in personalized healthcare. Per. Med. 7(5), 561-568 (2010).
14. Yeghiazaryan K, Bauriedel G, Schild HH, Golubnitschaja O: Prediction of degeneration of native and bioprosthetic aortic valves: issue-related particularities of diabetes mellitus. Infect. Disord. Drug Targets 8(2), 88-99 (2008). (Pubitemid 351936178)
15. Kotsopoulos J, Chen Z, Vallis KA, Poll A, Ainsworth P, Narod SA: DNA repair capacity as a possible biomarker of breast cancer risk in female BRCA1 mutation carriers. Br. J. Cancer 96(1), 118-125 (2007). (Pubitemid 46094648)
16. Sigurdson AJ, Hauptmann M, Alexander BH, et al.: DNA damage among thyroid cancer and multiple cancer cases, controls, and long-lived individuals. Mutat. Res. 586(2), 173-188 (2005). (Pubitemid 41749362)
17. Zhang C, Naftalis E, Euhus D: Carcinogen-induced DNA double strand break repair in sporadic breast cancer. J. Surg. Res. 135(1), 120-128 (2006). (Pubitemid 44215913)
18. Santos RA, Teixeira AC, Mayorano MB, Carrara HH, Andrade JM, Takahashi CS: Basal levels of DNA damage detected by micronuclei and comet assays in untreated breast cancer patients and healthy women. Clin. Exp. Med. 10(2), 87-92 (2010).
19. Moenkemann H, Flammer J, Wunderlich K, Breipohl W, Schild HH, Golubnitschaja O: Increased DNA breaks and up-regulation of both G(1) and G(2) checkpoint genes p21(WAF1/CIP1) and 14-13-3 s in circulating leukocytes of glaucoma patients and vasospastic individuals. Amino Acids 28(2), 199-205 (2005).
20. Szaflik JP, Janik-Papis K, Synowiec E, et al.: DNA damage and repair in age-related macular degeneration. Mutat. Res. 669(1-2), 169-176 (2009).
21. Barcelos GR, Grotto D, Serpeloni JM, et al.: Protective properties of quercetin against DNA damage and oxidative stress induced by methylmercury in rats. Arch. Toxicol. doi:10.1007/s00204-011-0652-y (2011) (Epub ahead of print).
22. Golubnitschaja O, Moenkemann H, Trog DB, Blom HJ, De Vriese AS: Activation of genes inducing cell-cycle arrest and of increased DNA repair in the hearts of rats with early streptozotocin-induced diabetes mellitus. Med. Sci. Monit. 12(2), BR68-BR74 (2006). (Pubitemid 43200940)
23. Hussien MM, McNulty H, Armstrong N, Johnston PG, Spence RA, Barnett Y: Investigation of systemic folate status, impact of alcohol intake and levels of DNA damage in mononuclear cells of breast cancer patients. Br. J. Cancer. 92(8), 1524-1530 (2005). (Pubitemid 40705021)
24. Golubnitschaja-Labudova O, Liu R, Decker C, Zhu P, Haefliger IO, Flammer J: Altered gene expression in lymphocytes of patients with normal-tension glaucoma. Curr. Eye Res. 21(5), 867-876 (2000). (Pubitemid 32209636)
25. Tice RR, Agurell E, Anderson D, et al.: Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ. Mol. Mutagen. 35(3), 206-221 (2000). (Pubitemid 30196665)
26. Golubnitschaja O, Moenkemann H, Kim K, Mozaffari MS: DNA damage and expression of checkpoint genes p21(WAF1/CIP1) and 14-3-3 s in taurine-deficient cardiomyocytes. Biochem. Pharmacol. 66(3), 511-517 (2003). (Pubitemid 36937037)
27. Mönkemann H, De Vriese AS, Blom HJ, et al.: Early molecular events in the development of the diabetic cardiomyopathy. Amino Acids 23(1-3), 331-336 (2002).
28. WHO Cancer 2006 www.who.int/mediacentre/factsheets/fs297/en/index.html